BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chan KC, Jiang P, Chan CW, Sun K, Wong J, Hui EP, Chan SL, Chan WC, Hui DS, Ng SS. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci USA. 2013;110:18761-18768. [PMID: 24191000 DOI: 10.1073/pnas.1313995110] [Cited by in Crossref: 229] [Cited by in F6Publishing: 204] [Article Influence: 25.4] [Reference Citation Analysis]
Number Citing Articles
1 Pellino G, Gallo G, Pallante P, Capasso R, De Stefano A, Maretto I, Malapelle U, Qiu S, Nikolaou S, Barina A, Clerico G, Reginelli A, Giuliani A, Sciaudone G, Kontovounisios C, Brunese L, Trompetto M, Selvaggi F. Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives. Gastroenterol Res Pract. 2018;2018:2397863. [PMID: 30008744 DOI: 10.1155/2018/2397863] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
2 Wong GLH. Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet. World J Hepatol 2015; 7(18): 2133-2135 [PMID: 26328024 DOI: 10.4254/wjh.v7.i18.2133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
3 Liu L, Toung JM, Jassowicz AF, Vijayaraghavan R, Kang H, Zhang R, Kruglyak KM, Huang HJ, Hinoue T, Shen H, Salathia NS, Hong DS, Naing A, Subbiah V, Piha-Paul SA, Bibikova M, Granger G, Barnes B, Shen R, Gutekunst K, Fu S, Tsimberidou AM, Lu C, Eng C, Moulder SL, Kopetz ES, Amaria RN, Meric-Bernstam F, Laird PW, Fan JB, Janku F. Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification. Ann Oncol 2018;29:1445-53. [PMID: 29635542 DOI: 10.1093/annonc/mdy119] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 12.3] [Reference Citation Analysis]
4 Lam WKJ, Chan KCA. Plasma DNA for early cancer detection - opportunities and challenges. Expert Rev Mol Diagn 2019;19:5-7. [PMID: 30513010 DOI: 10.1080/14737159.2019.1555476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Zeng C, Stroup EK, Zhang Z, Chiu BC, Zhang W. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy. Cancer Commun (Lond) 2019;39:12. [PMID: 30922396 DOI: 10.1186/s40880-019-0356-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
6 Kruglyak KM, Lin E, Ong FS. Next-Generation Sequencing and Applications to the Diagnosis and Treatment of Lung Cancer. Adv Exp Med Biol. 2016;890:123-136. [PMID: 26703802 DOI: 10.1007/978-3-319-24932-2_7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
7 Zeng H, He B, Yi C, Peng J. Liquid biopsies: DNA methylation analyses in circulating cell-free DNA. J Genet Genomics 2018;45:185-92. [PMID: 29706556 DOI: 10.1016/j.jgg.2018.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
8 Aravanis AM, Lee M, Klausner RD. Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection. Cell 2017;168:571-4. [PMID: 28187279 DOI: 10.1016/j.cell.2017.01.030] [Cited by in Crossref: 193] [Cited by in F6Publishing: 160] [Article Influence: 38.6] [Reference Citation Analysis]
9 Weiser DA, West-Szymanski DC, Fraint E, Weiner S, Rivas MA, Zhao CWT, He C, Applebaum MA. Progress toward liquid biopsies in pediatric solid tumors. Cancer Metastasis Rev 2019;38:553-71. [PMID: 31836951 DOI: 10.1007/s10555-019-09825-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14:531-548. [PMID: 28252003 DOI: 10.1038/nrclinonc.2017.14] [Cited by in Crossref: 770] [Cited by in F6Publishing: 743] [Article Influence: 154.0] [Reference Citation Analysis]
11 Li J, Zhou X, Liu X, Ren J, Wang J, Wang W, Zheng Y, Shi X, Sun T, Li Z, Kang A, Tang F, Wen L, Fu W. Detection of Colorectal Cancer in Circulating Cell-Free DNA by Methylated CpG Tandem Amplification and Sequencing. Clinical Chemistry 2019;65:916-26. [DOI: 10.1373/clinchem.2019.301804] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
12 Vaca-Paniagua F, Oliver J, Nogueira da Costa A, Merle P, McKay J, Herceg Z, Holmila R. Targeted deep DNA methylation analysis of circulating cell-free DNA in plasma using massively parallel semiconductor sequencing. Epigenomics 2015;7:353-62. [PMID: 26077425 DOI: 10.2217/epi.14.94] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
13 Xu H, Zhu X, Xu Z, Hu Y, Bo S, Xing T, Zhu K. Non-invasive Analysis of Genomic Copy Number Variation in Patients with Hepatocellular Carcinoma by Next Generation DNA Sequencing. J Cancer 2015;6:247-53. [PMID: 25663942 DOI: 10.7150/jca.10747] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
14 Liao W, Mao Y, Ge P, Yang H, Xu H, Lu X, Sang X, Zhong S. Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis. Medicine (Baltimore). 2015;94:e722. [PMID: 25860220 DOI: 10.1097/md.0000000000000722] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
15 van der Pol Y, Mouliere F. Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA. Cancer Cell 2019;36:350-68. [DOI: 10.1016/j.ccell.2019.09.003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 21.0] [Reference Citation Analysis]
16 Bronkhorst AJ, Ungerer V, Holdenrieder S. The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol Detect Quantif. 2019;17:100087. [PMID: 30923679 DOI: 10.1016/j.bdq.2019.100087] [Cited by in Crossref: 142] [Cited by in F6Publishing: 124] [Article Influence: 47.3] [Reference Citation Analysis]
17 Lissa D, Robles AI. Methylation analyses in liquid biopsy. Transl Lung Cancer Res 2016;5:492-504. [PMID: 27826530 DOI: 10.21037/tlcr.2016.10.03] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
18 Fateen W, Johnson PJ, Wood HM, Zhang H, He S, El-Meteini M, Wyatt JI, Aithal GP, Quirke P. Characterisation of dysplastic liver nodules using low-pass DNA sequencing and detection of chromosome arm-level abnormalities in blood-derived cell-free DNA. J Pathol 2021;255:30-40. [PMID: 34028025 DOI: 10.1002/path.5734] [Reference Citation Analysis]
19 O'Keefe CM, Giammanco D, Li S, Pisanic TR, Wang TJ. Multilayer microfluidic array for highly efficient sample loading and digital melt analysis of DNA methylation. Lab Chip 2019;19:444-51. [PMID: 30623957 DOI: 10.1039/c8lc01189c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Mannan AU, Singh J, Lakshmikeshava R, Thota N, Singh S, Sowmya TS, Mishra A, Sinha A, Deshwal S, Soni MR, Chandrasekar A, Ramesh B, Ramamurthy B, Padhi S, Manek P, Ramalingam R, Kapoor S, Ghosh M, Sankaran S, Ghosh A, Veeramachaneni V, Ramamoorthy P, Hariharan R, Subramanian K. Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India. J Hum Genet 2016;61:515-22. [PMID: 26911350 DOI: 10.1038/jhg.2016.4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
21 Peneder P, Stütz AM, Surdez D, Krumbholz M, Semper S, Chicard M, Sheffield NC, Pierron G, Lapouble E, Tötzl M, Ergüner B, Barreca D, Rendeiro AF, Agaimy A, Boztug H, Engstler G, Dworzak M, Bernkopf M, Taschner-Mandl S, Ambros IM, Myklebost O, Marec-Bérard P, Burchill SA, Brennan B, Strauss SJ, Whelan J, Schleiermacher G, Schaefer C, Dirksen U, Hutter C, Boye K, Ambros PF, Delattre O, Metzler M, Bock C, Tomazou EM. Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden. Nat Commun 2021;12:3230. [PMID: 34050156 DOI: 10.1038/s41467-021-23445-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F, Schellen P, Verschueren H, Post E, Koster J, Ylstra B, Ameziane N, Dorsman J, Smit EF, Verheul HM, Noske DP, Reijneveld JC, Nilsson RJA, Tannous BA, Wesseling P, Wurdinger T. RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics. Cancer Cell. 2015;28:666-676. [PMID: 26525104 DOI: 10.1016/j.ccell.2015.09.018] [Cited by in Crossref: 353] [Cited by in F6Publishing: 332] [Article Influence: 50.4] [Reference Citation Analysis]
23 Best MG, Sol N, In 't Veld SGJG, Vancura A, Muller M, Niemeijer AN, Fejes AV, Tjon Kon Fat LA, Huis In 't Veld AE, Leurs C, Le Large TY, Meijer LL, Kooi IE, Rustenburg F, Schellen P, Verschueren H, Post E, Wedekind LE, Bracht J, Esenkbrink M, Wils L, Favaro F, Schoonhoven JD, Tannous J, Meijers-Heijboer H, Kazemier G, Giovannetti E, Reijneveld JC, Idema S, Killestein J, Heger M, de Jager SC, Urbanus RT, Hoefer IE, Pasterkamp G, Mannhalter C, Gomez-Arroyo J, Bogaard HJ, Noske DP, Vandertop WP, van den Broek D, Ylstra B, Nilsson RJA, Wesseling P, Karachaliou N, Rosell R, Lee-Lewandrowski E, Lewandrowski KB, Tannous BA, de Langen AJ, Smit EF, van den Heuvel MM, Wurdinger T. Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets. Cancer Cell 2017;32:238-252.e9. [PMID: 28810146 DOI: 10.1016/j.ccell.2017.07.004] [Cited by in Crossref: 99] [Cited by in F6Publishing: 101] [Article Influence: 19.8] [Reference Citation Analysis]
24 Meng Z, Ren Q, Zhong G, Li S, Chen Y, Wu W, Feng Y, Mao M, Zhang F, Long G. Noninvasive Detection of Hepatocellular Carcinoma with Circulating Tumor DNA Features and α-Fetoprotein. J Mol Diagn 2021;23:1174-84. [PMID: 34182124 DOI: 10.1016/j.jmoldx.2021.06.003] [Reference Citation Analysis]
25 Vymetalkova V, Cervena K, Bartu L, Vodicka P. Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review. Int J Mol Sci 2018;19:E3356. [PMID: 30373199 DOI: 10.3390/ijms19113356] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 10.5] [Reference Citation Analysis]
26 Tost J. Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns. In: Jeltsch A, Jurkowska RZ, editors. DNA Methyltransferases - Role and Function. Cham: Springer International Publishing; 2016. pp. 343-430. [DOI: 10.1007/978-3-319-43624-1_15] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
27 Feng Y, Jiang Y, Feng Q, Xu L, Jiang Y, Meng F, Shu X. A novel prognostic biomarker for muscle invasive bladder urothelial carcinoma based on 11 DNA methylation signature. Cancer Biol Ther 2020;21:1119-27. [PMID: 33151129 DOI: 10.1080/15384047.2020.1833811] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Han DSC, Ni M, Chan RWY, Wong DKL, Hiraki LT, Volpi S, Jiang P, Lui KO, Chan KCA, Chiu RWK, Lo YMD. Nuclease deficiencies alter plasma cell-free DNA methylation profiles. Genome Res 2021;31:2008-21. [PMID: 34470801 DOI: 10.1101/gr.275426.121] [Reference Citation Analysis]
29 Stewart CM, Tsui DWY. Circulating cell-free DNA for non-invasive cancer management. Cancer Genet 2018;228-229:169-79. [PMID: 29625863 DOI: 10.1016/j.cancergen.2018.02.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
30 Wang YH, Song Z, Hu XY, Wang HS. Circulating tumor DNA analysis for tumor diagnosis. Talanta 2021;228:122220. [PMID: 33773726 DOI: 10.1016/j.talanta.2021.122220] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Davis AA, Iams WT, Chan D, Oh MS, Lentz RW, Peterman N, Robertson A, Shah A, Srivas R, Wilson TJ, Lambert NJ, George PS, Wong B, Wood HW, Close JC, Tezcan A, Nesmith K, Tezcan H, Chae YK. Early Assessment of Molecular Progression and Response by Whole-genome Circulating Tumor DNA in Advanced Solid Tumors. Mol Cancer Ther 2020;19:1486-96. [PMID: 32371589 DOI: 10.1158/1535-7163.MCT-19-1060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Huang J, Soupir AC, Schlick BD, Teng M, Sahin IH, Permuth JB, Siegel EM, Manley BJ, Pellini B, Wang L. Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA. Cancers (Basel) 2021;13:5611. [PMID: 34830765 DOI: 10.3390/cancers13225611] [Reference Citation Analysis]
33 Li F, Wei F, Huang WL, Lin CC, Li L, Shen MM, Yan Q, Liao W, Chia D, Tu M, Tang JH, Feng Z, Kim Y, Su WC, Wong DTW. Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) Patients. Cancers (Basel) 2020;12:E2041. [PMID: 32722209 DOI: 10.3390/cancers12082041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Luchini C, Veronese N, Nottegar A, Cappelletti V, Daidone MG, Smith L, Parris C, Brosens LAA, Caruso MG, Cheng L, Wolfgang CL, Wood LD, Milella M, Salvia R, Scarpa A. Liquid Biopsy as Surrogate for Tissue for Molecular Profiling in Pancreatic Cancer: A Meta-Analysis Towards Precision Medicine. Cancers (Basel) 2019;11:E1152. [PMID: 31405192 DOI: 10.3390/cancers11081152] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
35 Tao K, Bian Z, Zhang Q, Guo X, Yin C, Wang Y, Zhou K, Wan S, Shi M, Bao D, Yang C, Xing J. Machine learning-based genome-wide interrogation of somatic copy number aberrations in circulating tumor DNA for early detection of hepatocellular carcinoma. EBioMedicine 2020;56:102811. [PMID: 32512514 DOI: 10.1016/j.ebiom.2020.102811] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
36 Larson MH, Pan W, Kim HJ, Mauntz RE, Stuart SM, Pimentel M, Zhou Y, Knudsgaard P, Demas V, Aravanis AM, Jamshidi A. A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection. Nat Commun 2021;12:2357. [PMID: 33883548 DOI: 10.1038/s41467-021-22444-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
37 Yang X, Dai W, Kwong DL, Szeto CY, Wong EH, Ng WT, Lee AW, Ngan RK, Yau CC, Tung SY, Lung ML. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting. Int J Cancer 2015;136:E127-35. [PMID: 25196065 DOI: 10.1002/ijc.29192] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
38 Wan N, Weinberg D, Liu TY, Niehaus K, Ariazi EA, Delubac D, Kannan A, White B, Bailey M, Bertin M, Boley N, Bowen D, Cregg J, Drake AM, Ennis R, Fransen S, Gafni E, Hansen L, Liu Y, Otte GL, Pecson J, Rice B, Sanderson GE, Sharma A, St John J, Tang C, Tzou A, Young L, Putcha G, Haque IS. Machine learning enables detection of early-stage colorectal cancer by whole-genome sequencing of plasma cell-free DNA. BMC Cancer 2019;19:832. [PMID: 31443703 DOI: 10.1186/s12885-019-6003-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
39 Dharajiya NG, Grosu DS, Farkas DH, McCullough RM, Almasri E, Sun Y, Kim SK, Jensen TJ, Saldivar JS, Topol EJ, van den Boom D, Ehrich M. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing. Clin Chem 2018;64:329-35. [PMID: 28982650 DOI: 10.1373/clinchem.2017.277517] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
40 Iglesias MS, Grzelczak M. Using gold nanoparticles to detect single-nucleotide polymorphisms: toward liquid biopsy. Beilstein J Nanotechnol 2020;11:263-84. [PMID: 32082965 DOI: 10.3762/bjnano.11.20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
41 Kageyama SI, Nihei K, Karasawa K, Sawada T, Koizumi F, Yamaguchi S, Kato S, Hojo H, Motegi A, Tsuchihara K, Akimoto T. Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients. Oncotarget 2018;9:19368-78. [PMID: 29721209 DOI: 10.18632/oncotarget.25053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
42 Miller BF, Pisanic Ii TR, Margolin G, Petrykowska HM, Athamanolap P, Goncearenco A, Osei-Tutu A, Annunziata CM, Wang TH, Elnitski L. Leveraging locus-specific epigenetic heterogeneity to improve the performance of blood-based DNA methylation biomarkers. Clin Epigenetics 2020;12:154. [PMID: 33081832 DOI: 10.1186/s13148-020-00939-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Palmirotta R, Lovero D, Cafforio P, Felici C, Mannavola F, Pellè E, Quaresmini D, Tucci M, Silvestris F. Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Ther Adv Med Oncol 2018;10:1758835918794630. [PMID: 30181785 DOI: 10.1177/1758835918794630] [Cited by in Crossref: 149] [Cited by in F6Publishing: 136] [Article Influence: 37.3] [Reference Citation Analysis]
44 Jiang P, Chan CW, Chan KC, Cheng SH, Wong J, Wong VW, Wong GL, Chan SL, Mok TS, Chan HL, Lai PB, Chiu RW, Lo YM. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci U S A 2015;112:E1317-25. [PMID: 25646427 DOI: 10.1073/pnas.1500076112] [Cited by in Crossref: 338] [Cited by in F6Publishing: 309] [Article Influence: 48.3] [Reference Citation Analysis]
45 Lam WKJ, Jiang P, Chan KCA, Peng W, Shang H, Heung MMS, Cheng SH, Zhang H, Tse OYO, Raghupathy R, Ma BBY, Hui EP, Chan ATC, Woo JKS, Chiu RWK, Lo YMD. Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases. Nat Commun 2019;10:3256. [PMID: 31332191 DOI: 10.1038/s41467-019-11226-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
46 Ren J, Lu P, Zhou X, Liao Y, Liu X, Li J, Wang W, Wang J, Wen L, Fu W, Tang F. Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer Patients. Clin Chem 2021:hvab204. [PMID: 34791072 DOI: 10.1093/clinchem/hvab204] [Reference Citation Analysis]
47 Yu SC, Chan KC, Zheng YW, Jiang P, Liao GJ, Sun H, Akolekar R, Leung TY, Go AT, van Vugt JM, Minekawa R, Oudejans CB, Nicolaides KH, Chiu RW, Lo YM. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. Proc Natl Acad Sci U S A 2014;111:8583-8. [PMID: 24843150 DOI: 10.1073/pnas.1406103111] [Cited by in Crossref: 163] [Cited by in F6Publishing: 150] [Article Influence: 20.4] [Reference Citation Analysis]
48 Gai W, Ji L, Lam WKJ, Sun K, Jiang P, Chan AWH, Wong J, Lai PBS, Ng SSM, Ma BBY, Wong GLH, Wong VWS, Chan HLY, Chiu RWK, Lo YMD, Chan KCA. Liver- and Colon-Specific DNA Methylation Markers in Plasma for Investigation of Colorectal Cancers with or without Liver Metastases. Clin Chem 2018;64:1239-49. [PMID: 29903871 DOI: 10.1373/clinchem.2018.290304] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 9.5] [Reference Citation Analysis]
49 Cai J, Chen L, Zhang Z, Zhang X, Lu X, Liu W, Shi G, Ge Y, Gao P, Yang Y, Ke A, Xiao L, Dong R, Zhu Y, Yang X, Wang J, Zhu T, Yang D, Huang X, Sui C, Qiu S, Shen F, Sun H, Zhou W, Zhou J, Nie J, Zeng C, Stroup EK, Chiu BC, Lau WY, He C, Wang H, Zhang W, Fan J. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. Gut. 2019;68:2195-2205. [PMID: 31358576 DOI: 10.1136/gutjnl-2019-318882] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 19.7] [Reference Citation Analysis]
50 Bond DR, Uddipto K, Enjeti AK, Lee HJ. Single-cell epigenomics in cancer: charting a course to clinical impact. Epigenomics 2020;12:1139-51. [PMID: 32790506 DOI: 10.2217/epi-2020-0046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Kang S, Li Q, Chen Q, Zhou Y, Park S, Lee G, Grimes B, Krysan K, Yu M, Wang W, Alber F, Sun F, Dubinett SM, Li W, Zhou XJ. CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biol 2017;18:53. [PMID: 28335812 DOI: 10.1186/s13059-017-1191-5] [Cited by in Crossref: 111] [Cited by in F6Publishing: 94] [Article Influence: 22.2] [Reference Citation Analysis]
52 Burgener JM, Rostami A, De Carvalho DD, Bratman SV. Cell-free DNA as a post-treatment surveillance strategy: current status. Seminars in Oncology 2017;44:330-46. [DOI: 10.1053/j.seminoncol.2018.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
53 Yang F, Tang J, Zhao Z, Zhao C, Xiang Y. Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer. Reprod Biol Endocrinol 2021;19:178. [PMID: 34861867 DOI: 10.1186/s12958-021-00860-8] [Reference Citation Analysis]
54 Belic J, Koch M, Ulz P, Auer M, Gerhalter T, Mohan S, Fischereder K, Petru E, Bauernhofer T, Geigl JB, Speicher MR, Heitzer E. mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA. Adv Exp Med Biol 2016;924:147-55. [PMID: 27753036 DOI: 10.1007/978-3-319-42044-8_28] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
55 Constâncio V, Nunes SP, Henrique R, Jerónimo C. DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types. Cells 2020;9:E624. [PMID: 32150897 DOI: 10.3390/cells9030624] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
56 Zhang J, Liu X, Zhang S, Cai Y, Ma K, Hua K, Cui Y. A site-specific DNA methylation biosensor for both visual and magnetic determination based on lateral flow assay. Analyst 2021;146:2248-54. [PMID: 33599220 DOI: 10.1039/d0an02277b] [Reference Citation Analysis]
57 Zhang H, Dong P, Guo S, Tao C, Chen W, Zhao W, Wang J, Cheung R, Villanueva A, Fan J, Ding H, Schrodi SJ, Zhang D, Zeng C. Hypomethylation in HBV integration regions aids non-invasive surveillance to hepatocellular carcinoma by low-pass genome-wide bisulfite sequencing. BMC Med 2020;18:200. [PMID: 32741373 DOI: 10.1186/s12916-020-01667-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
58 Cui Y, Li H, Zhan H, Han T, Dong Y, Tian C, Guo Y, Yan F, Dai D, Liu P. Identification of Potential Biomarkers for Liver Cancer Through Gene Mutation and Clinical Characteristics. Front Oncol 2021;11:733478. [PMID: 34604069 DOI: 10.3389/fonc.2021.733478] [Reference Citation Analysis]
59 Li W, Li Q, Kang S, Same M, Zhou Y, Sun C, Liu CC, Matsuoka L, Sher L, Wong WH, Alber F, Zhou XJ. CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data. Nucleic Acids Res 2018;46:e89. [PMID: 29897492 DOI: 10.1093/nar/gky423] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 19.0] [Reference Citation Analysis]
60 Cheng THT, Jiang P, Teoh JYC, Heung MMS, Tam JCW, Sun X, Lee WS, Ni M, Chan RCK, Ng CF, Chan KCA, Chiu RWK, Lo YMD. Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling. Clin Chem 2019;65:927-36. [PMID: 30988170 DOI: 10.1373/clinchem.2018.301341] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
61 Lo YM. Noninvasive prenatal diagnosis: from dream to reality. Clin Chem 2015;61:32-7. [PMID: 25274552 DOI: 10.1373/clinchem.2014.223024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
62 Cai X, Janku F, Zhan Q, Fan JB. Accessing Genetic Information with Liquid Biopsies. Trends Genet 2015;31:564-75. [PMID: 26450339 DOI: 10.1016/j.tig.2015.06.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 11.0] [Reference Citation Analysis]
63 Song CX, Diao J, Brunger AT, Quake SR. Simultaneous single-molecule epigenetic imaging of DNA methylation and hydroxymethylation. Proc Natl Acad Sci U S A 2016;113:4338-43. [PMID: 27035984 DOI: 10.1073/pnas.1600223113] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
64 Wang HQ, Yang CY, Wang SY, Wang T, Han JL, Wei K, Liu FC, Xu JD, Peng XZ, Wang JM. Cell-free plasma hypermethylated CASZ1, CDH13 and ING2 are promising biomarkers of esophageal cancer. J Biomed Res 2018;32:424-33. [PMID: 30355852 DOI: 10.7555/JBR.32.20170065] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
65 Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, Jensen SØ, Medina JE, Hruban C, White JR, Palsgrove DN, Niknafs N, Anagnostou V, Forde P, Naidoo J, Marrone K, Brahmer J, Woodward BD, Husain H, van Rooijen KL, Ørntoft MW, Madsen AH, van de Velde CJH, Verheij M, Cats A, Punt CJA, Vink GR, van Grieken NCT, Koopman M, Fijneman RJA, Johansen JS, Nielsen HJ, Meijer GA, Andersen CL, Scharpf RB, Velculescu VE. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature 2019;570:385-9. [PMID: 31142840 DOI: 10.1038/s41586-019-1272-6] [Cited by in Crossref: 240] [Cited by in F6Publishing: 206] [Article Influence: 80.0] [Reference Citation Analysis]
66 Maggi EC, Gravina S, Cheng H, Piperdi B, Yuan Z, Dong X, Libutti SK, Vijg J, Montagna C. Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model. Front Genet 2018;9:6. [PMID: 29410677 DOI: 10.3389/fgene.2018.00006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
67 Sun Z, Cunningham J, Slager S, Kocher JP. Base resolution methylome profiling: considerations in platform selection, data preprocessing and analysis. Epigenomics 2015;7:813-28. [PMID: 26366945 DOI: 10.2217/epi.15.21] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 9.6] [Reference Citation Analysis]
68 Zhang Y, Liu Z, Ji K, Li X, Wang C, Ren Z, Liu Y, Chen X, Han X, Meng L, Li L, Li Z. Clinical Application Value of Circulating Cell-free DNA in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:736330. [PMID: 34660697 DOI: 10.3389/fmolb.2021.736330] [Reference Citation Analysis]
69 Qin Z, Ljubimov VA, Zhou C, Tong Y, Liang J. Cell-free circulating tumor DNA in cancer. Chin J Cancer 2016;35:36. [PMID: 27056366 DOI: 10.1186/s40880-016-0092-4] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 12.3] [Reference Citation Analysis]
70 Bratulic S, Gatto F, Nielsen J. The Translational Status of Cancer Liquid Biopsies. Regen Eng Transl Med . [DOI: 10.1007/s40883-019-00141-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 4.3] [Reference Citation Analysis]
71 Sun K, Jiang P, Chan KC. The impact of digital DNA counting technologies on noninvasive prenatal testing. Expert Rev Mol Diagn 2015;15:1261-8. [PMID: 26358092 DOI: 10.1586/14737159.2015.1084227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
72 Micevic G, Theodosakis N, Taube JM, Bosenberg MW, Rodić N. Attenuation of genome-wide 5-methylcytosine level is an epigenetic feature of cutaneous malignant melanomas. Melanoma Res 2017;27:85-96. [PMID: 27997431 DOI: 10.1097/CMR.0000000000000315] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
73 Celec P, Vlková B, Lauková L, Bábíčková J, Boor P. Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases. Expert Rev Mol Med 2018;20:e1. [PMID: 29343314 DOI: 10.1017/erm.2017.12] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
74 Bailleux C, Lacroix L, Barranger E, Delaloge S. Using methylation signatures on cell-free DNA for early cancer detection: a new era in liquid biopsy? Ann Oncol 2020;31:665-7. [PMID: 32289381 DOI: 10.1016/j.annonc.2020.03.307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
75 Romero R. A Profile of Dennis Lo, DM, DPhil, FRCP, FRCPath, FRS. Am J Obstet Gynecol 2018;218:371-8. [PMID: 29598980 DOI: 10.1016/j.ajog.2018.01.027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
76 Ookawa S, Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Ohtaki S, Noshiro S, Komatsu K, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O. Digital Polymerase Chain Reaction Quantification of SERPINA1 Predicts Prognosis in High-Grade Glioma. World Neurosurg 2018;111:e783-9. [PMID: 29309973 DOI: 10.1016/j.wneu.2017.12.166] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
77 Lu M, Zhan X. The crucial role of multiomic approach in cancer research and clinically relevant outcomes. EPMA J 2018;9:77-102. [PMID: 29515689 DOI: 10.1007/s13167-018-0128-8] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 25.0] [Reference Citation Analysis]
78 Belic J, Koch M, Ulz P, Auer M, Gerhalter T, Mohan S, Fischereder K, Petru E, Bauernhofer T, Geigl JB, Speicher MR, Heitzer E. Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach. Clinical Chemistry 2015;61:838-49. [DOI: 10.1373/clinchem.2014.234286] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 9.3] [Reference Citation Analysis]
79 Keravnou A, Ioannides M, Tsangaras K, Loizides C, Hadjidaniel MD, Papageorgiou EA, Kyriakou S, Antoniou P, Mina P, Achilleos A, Neofytou M, Kypri E, Sismani C, Koumbaris G, Patsalis PC. Whole-genome fetal and maternal DNA methylation analysis using MeDIP-NGS for the identification of differentially methylated regions. Genet Res (Camb) 2016;98:e15. [PMID: 27834155 DOI: 10.1017/S0016672316000136] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
80 Cheng TH, Jiang P, Tam JC, Sun X, Lee W, Yu SC, Teoh JY, Chiu PK, Ng C, Chow K, Szeto C, Chan KA, Chiu RW, Lo YD. Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA. Clinical Biochemistry 2017;50:496-501. [DOI: 10.1016/j.clinbiochem.2017.02.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
81 Zhao EY, Bratman SV. Emerging Precision Oncology Applications of Liquid Biopsy using Circulating Tumour DNA and Methylome Profiling. Clin Oncol (R Coll Radiol) 2020;32:626-31. [PMID: 32586654 DOI: 10.1016/j.clon.2020.05.022] [Reference Citation Analysis]
82 Yokokawa T, Misaka T, Kimishima Y, Shimizu T, Kaneshiro T, Takeishi Y. Clinical Significance of Circulating Cardiomyocyte-Specific Cell-Free DNA in Patients With Heart Failure: A Proof-of-Concept Study. Can J Cardiol 2020;36:931-5. [PMID: 32001048 DOI: 10.1016/j.cjca.2019.10.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Chan RW, Jiang P, Peng X, Tam LS, Liao GJ, Li EK, Wong PC, Sun H, Chan KC, Chiu RW, Lo YM. Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing. Proc Natl Acad Sci U S A 2014;111:E5302-11. [PMID: 25427797 DOI: 10.1073/pnas.1421126111] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 8.6] [Reference Citation Analysis]
84 Van Paemel R, De Koker A, Vandeputte C, van Zogchel L, Lammens T, Laureys G, Vandesompele J, Schleiermacher G, Chicard M, Van Roy N, Vicha A, Tytgat GAM, Callewaert N, De Preter K, De Wilde B. Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study. Epigenetics 2021;16:196-208. [PMID: 32662719 DOI: 10.1080/15592294.2020.1790950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Han Y, Ji L, Guan Y, Ma M, Li P, Xue Y, Zhang Y, Huang W, Gong Y, Jiang L, Wang X, Xie H, Zhou B, Wang J, Wang J, Han J, Deng Y, Yi X, Gao F, Huang J. An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome. Clin Transl Med 2021;11:e498. [PMID: 34323415 DOI: 10.1002/ctm2.498] [Reference Citation Analysis]
86 Tanić M, Beck S. Epigenome-wide association studies for cancer biomarker discovery in circulating cell-free DNA: technical advances and challenges. Current Opinion in Genetics & Development 2017;42:48-55. [DOI: 10.1016/j.gde.2017.01.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
87 Jiang P, Sun K, Lun FM, Guo AM, Wang H, Chan KC, Chiu RW, Lo YM, Sun H. Methy-Pipe: an integrated bioinformatics pipeline for whole genome bisulfite sequencing data analysis. PLoS One 2014;9:e100360. [PMID: 24945300 DOI: 10.1371/journal.pone.0100360] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
88 Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17:223-238. [PMID: 28233803 DOI: 10.1038/nrc.2017.7] [Cited by in Crossref: 967] [Cited by in F6Publishing: 884] [Article Influence: 193.4] [Reference Citation Analysis]
89 Su YH, Lin SY, Song W, Jain S. DNA markers in molecular diagnostics for hepatocellular carcinoma. Expert Rev Mol Diagn. 2014;14:803-817. [PMID: 25098554 DOI: 10.1586/14737159.2014.946908] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
90 Verlingue L, Alt M, Kamal M, Sablin MP, Zoubir M, Bousetta N, Pierga JY, Servant N, Paoletti X, Le Tourneau C. Challenges for the implementation of high-throughput testing and liquid biopsies in personalized medicine cancer trials. Per Med 2014;11:545-58. [PMID: 29758779 DOI: 10.2217/pme.14.30] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
91 Yadav DK, Bai X, Yadav RK, Singh A, Li G, Ma T, Chen W, Liang T. Liquid biopsy in pancreatic cancer: the beginning of a new era. Oncotarget 2018;9:26900-33. [PMID: 29928492 DOI: 10.18632/oncotarget.24809] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
92 Wong VW, Janssen HL. Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection? J Hepatol. 2015;63:722-732. [PMID: 26026875 DOI: 10.1016/j.jhep.2015.05.019] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 8.4] [Reference Citation Analysis]
93 Li CM, Chu WY, Wong DL, Tsang HF, Tsui NBY, Chan CML, Xue VWW, Siu PMF, Yung BYM, Chan LWC, Wong SCC. Current and future molecular diagnostics in non-small-cell lung cancer. Expert Review of Molecular Diagnostics 2015;15:1061-74. [DOI: 10.1586/14737159.2015.1063420] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
94 Cheung AH, Chow C, To KF. Latest development of liquid biopsy. J Thorac Dis 2018;10:S1645-51. [PMID: 30034830 DOI: 10.21037/jtd.2018.04.68] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
95 Henrique R, Jerónimo C. DNA hypomethylation in plasma as a cancer biomarker: when less is more? Expert Rev Mol Diagn 2014;14:419-22. [PMID: 24689646 DOI: 10.1586/14737159.2014.905203] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
96 Soda N, Rehm BHA, Sonar P, Nguyen NT, Shiddiky MJA. Advanced liquid biopsy technologies for circulating biomarker detection. J Mater Chem B 2019;7:6670-704. [PMID: 31646316 DOI: 10.1039/c9tb01490j] [Cited by in Crossref: 41] [Cited by in F6Publishing: 19] [Article Influence: 13.7] [Reference Citation Analysis]
97 Dawson SJ. Characterizing the Cancer Genome in Blood. Cold Spring Harb Perspect Med 2019;9:a026880. [PMID: 29844219 DOI: 10.1101/cshperspect.a026880] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
98 Del Vecchio G, Li Q, Li W, Thamotharan S, Tosevska A, Morselli M, Sung K, Janzen C, Zhou X, Pellegrini M, Devaskar SU. Cell-free DNA Methylation and Transcriptomic Signature Prediction of Pregnancies with Adverse Outcomes. Epigenetics 2021;16:642-61. [PMID: 33045922 DOI: 10.1080/15592294.2020.1816774] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
99 Chang Y, Tolani B, Nie X, Zhi X, Hu M, He B. Review of the clinical applications and technological advances of circulating tumor DNA in cancer monitoring. Ther Clin Risk Manag 2017;13:1363-74. [PMID: 29066904 DOI: 10.2147/TCRM.S141991] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
100 Chitty LS, Lo YM. Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNA. Cold Spring Harb Perspect Med 2015;5:a023085. [PMID: 26187875 DOI: 10.1101/cshperspect.a023085] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 5.9] [Reference Citation Analysis]
101 Adalsteinsson VA, Ha G, Freeman SS, Choudhury AD, Stover DG, Parsons HA, Gydush G, Reed SC, Rotem D, Rhoades J, Loginov D, Livitz D, Rosebrock D, Leshchiner I, Kim J, Stewart C, Rosenberg M, Francis JM, Zhang CZ, Cohen O, Oh C, Ding H, Polak P, Lloyd M, Mahmud S, Helvie K, Merrill MS, Santiago RA, O'Connor EP, Jeong SH, Leeson R, Barry RM, Kramkowski JF, Zhang Z, Polacek L, Lohr JG, Schleicher M, Lipscomb E, Saltzman A, Oliver NM, Marini L, Waks AG, Harshman LC, Tolaney SM, Van Allen EM, Winer EP, Lin NU, Nakabayashi M, Taplin ME, Johannessen CM, Garraway LA, Golub TR, Boehm JS, Wagle N, Getz G, Love JC, Meyerson M. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat Commun. 2017;8:1324. [PMID: 29109393 DOI: 10.1038/s41467-017-00965-y] [Cited by in Crossref: 267] [Cited by in F6Publishing: 231] [Article Influence: 53.4] [Reference Citation Analysis]
102 Ng CKY, Di Costanzo GG, Terracciano LM, Piscuoglio S. Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and Outlook. Front Med (Lausanne). 2018;5:78. [PMID: 29632864 DOI: 10.3389/fmed.2018.00078] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
103 Yuan F, Yu Y, Zhou Y, Zhang X. 5hmC-MIQuant: Ultrasensitive Quantitative Detection of 5-Hydroxymethylcytosine in Low-Input Cell-Free DNA Samples. Anal Chem 2020;92:1605-10. [DOI: 10.1021/acs.analchem.9b04920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
104 Karin-Kujundzic V, Sola IM, Predavec N, Potkonjak A, Somen E, Mioc P, Serman A, Vranic S, Serman L. Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers. Cells 2019;8:E1459. [PMID: 31752198 DOI: 10.3390/cells8111459] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
105 Zhou K, Liu Y, Yuan Q, Lai D, Guo S, Wang Z, Su L, Zhang H, Wang X, Guo W, Ji X, Gu X, Huang Q, Guo X, Xing J. Next-Generation Sequencing-Based Analysis of Urine Cell-Free mtDNA Reveals Aberrant Fragmentation and Mutation Profile in Cancer Patients. Clin Chem 2022:hvab268. [PMID: 34993545 DOI: 10.1093/clinchem/hvab268] [Reference Citation Analysis]
106 Liu Y, Song C, Ladas I, Fitarelli-Kiehl M, Makrigiorgos GM. Methylation-sensitive enrichment of minor DNA alleles using a double-strand DNA-specific nuclease. Nucleic Acids Res 2017;45:e39. [PMID: 27903892 DOI: 10.1093/nar/gkw1166] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
107 Sun K, Jiang P, Chan KC, Wong J, Cheng YK, Liang RH, Chan WK, Ma ES, Chan SL, Cheng SH. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc Natl Acad Sci USA. 2015;112:E5503-E5512. [PMID: 26392541 DOI: 10.1073/pnas.1508736112] [Cited by in Crossref: 349] [Cited by in F6Publishing: 302] [Article Influence: 49.9] [Reference Citation Analysis]
108 Heitzer E, Ulz P, Geigl JB. Circulating Tumor DNA as a Liquid Biopsy for Cancer. Clinical Chemistry 2015;61:112-23. [DOI: 10.1373/clinchem.2014.222679] [Cited by in Crossref: 469] [Cited by in F6Publishing: 413] [Article Influence: 67.0] [Reference Citation Analysis]
109 Chu D, Paoletti C, Gersch C, VanDenBerg DA, Zabransky DJ, Cochran RL, Wong HY, Toro PV, Cidado J, Croessmann S, Erlanger B, Cravero K, Kyker-Snowman K, Button B, Parsons HA, Dalton WB, Gillani R, Medford A, Aung K, Tokudome N, Chinnaiyan AM, Schott A, Robinson D, Jacks KS, Lauring J, Hurley PJ, Hayes DF, Rae JM, Park BH. ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients. Clin Cancer Res 2016;22:993-9. [PMID: 26261103 DOI: 10.1158/1078-0432.CCR-15-0943] [Cited by in Crossref: 117] [Cited by in F6Publishing: 64] [Article Influence: 16.7] [Reference Citation Analysis]
110 Jia S, Xie L, Li L, Qian Y, Wang J, Wang S, Zhang W, Qian B. Values of liquid biopsy in early detection of cancer: results from meta-analysis. Expert Rev Mol Diagn 2021;21:417-27. [PMID: 33770449 DOI: 10.1080/14737159.2021.1910025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Gorgannezhad L, Umer M, Islam MN, Nguyen NT, Shiddiky MJA. Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies. Lab Chip. 2018;18:1174-1196. [PMID: 29569666 DOI: 10.1039/c8lc00100f] [Cited by in Crossref: 125] [Cited by in F6Publishing: 67] [Article Influence: 31.3] [Reference Citation Analysis]
112 Chauhan A, Kaur R, Ghoshal S, Pal A. Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy. Indian J Clin Biochem 2021;36:131-42. [PMID: 33867703 DOI: 10.1007/s12291-020-00923-4] [Reference Citation Analysis]
113 Song CX, Yin S, Ma L, Wheeler A, Chen Y, Zhang Y, Liu B, Xiong J, Zhang W, Hu J, Zhou Z, Dong B, Tian Z, Jeffrey SS, Chua MS, So S, Li W, Wei Y, Diao J, Xie D, Quake SR. 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages. Cell Res. 2017;27:1231-1242. [PMID: 28820176 DOI: 10.1038/cr.2017.106] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 18.0] [Reference Citation Analysis]
114 Galot R, Machiels JH. Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN). Cancer Treat Rev 2020;85:101992. [PMID: 32092618 DOI: 10.1016/j.ctrv.2020.101992] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
115 Dennis Lo YM. Screening of Fetal Chromosomal Aneuploidy by Noninvasive Prenatal Testing: From Innovation to Setting Public Health Agendas to Potential Impact on Other Fields. Clin Chem 2020;66:25-8. [PMID: 31628140 DOI: 10.1373/clinchem.2019.303230] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Sun K, Jiang P, Wong AIC, Cheng YKY, Cheng SH, Zhang H, Chan KCA, Leung TY, Chiu RWK, Lo YMD. Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing.Proc Natl Acad Sci USA. 2018;115:E5106-E5114. [PMID: 29760053 DOI: 10.1073/pnas.1804134115] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 14.5] [Reference Citation Analysis]
117 Li J, Wei L, Zhang X, Zhang W, Wang H, Zhong B, Xie Z, Lv H, Wang X. DISMIR: Deep learning-based noninvasive cancer detection by integrating DNA sequence and methylation information of individual cell-free DNA reads. Brief Bioinform 2021:bbab250. [PMID: 34245239 DOI: 10.1093/bib/bbab250] [Reference Citation Analysis]
118 Chen H, Zhang J, Chen HY, Su B, Lu D. Establishment of multiplex allele-specific blocker PCR for enrichment and detection of 4 common EGFR mutations in non-small cell lung cancer. Ann Transl Med 2020;8:1509. [PMID: 33313254 DOI: 10.21037/atm-20-6754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Li Z, Guo X, Tang L, Peng L, Chen M, Luo X, Wang S, Xiao Z, Deng Z, Dai L, Xia K, Wang J. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing. Tumour Biol 2016;37:13111-9. [PMID: 27449045 DOI: 10.1007/s13277-016-5190-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
120 Cirmena G, Garuti A, De Mariano M, Coco S, Ferrando L, Isnaldi E, Barbero V, Fregatti P, Del Mastro L, Ferrando F, Gonella R, Garlaschi A, Friedman D, Ballestrero A, Zoppoli G. Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. J Oncol 2020;2020:8132507. [PMID: 32377196 DOI: 10.1155/2020/8132507] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
121 Siejka-Zielińska P, Cheng J, Jackson F, Liu Y, Soonawalla Z, Reddy S, Silva M, Puta L, McCain MV, Culver EL, Bekkali N, Schuster-Böckler B, Palamara PF, Mann D, Reeves H, Barnes E, Sivakumar S, Song CX. Cell-free DNA TAPS provides multimodal information for early cancer detection. Sci Adv 2021;7:eabh0534. [PMID: 34516908 DOI: 10.1126/sciadv.abh0534] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Papatheodoridi A, Chatzigeorgiou A, Chrysavgis L, Lembessis P, Loglio A, Facchetti F, Cholongitas E, Koutsilieris M, Lampertico P, Papatheodoridis G. Circulating cell-free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients. J Viral Hepat 2021;28:464-74. [PMID: 33260272 DOI: 10.1111/jvh.13446] [Reference Citation Analysis]
123 Chan SL, Yeo W. Development of systemic therapy for hepatocellular carcinoma at 2013: Updates and insights. World J Gastroenterol 2014; 20(12): 3135-3145 [PMID: 24696599 DOI: 10.3748/wjg.v20.i12.3135] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
124 Wang Z, Cheng G, Han X, Mu X, Zhang Y, Cui D, Liu C, Zhang L, Fan Z, Ma L, Yang L, Di J, Cram DS, Shi Y, Liu D. Application of Single-Molecule Amplification and Resequencing Technology for Broad Surveillance of Plasma Mutations in Patients with Advanced Lung Adenocarcinoma. J Mol Diagn 2017;19:169-81. [PMID: 27870944 DOI: 10.1016/j.jmoldx.2016.09.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
125 Han X, Wang J, Sun Y. Circulating Tumor DNA as Biomarkers for Cancer Detection. Genomics Proteomics Bioinformatics 2017;15:59-72. [PMID: 28392479 DOI: 10.1016/j.gpb.2016.12.004] [Cited by in Crossref: 113] [Cited by in F6Publishing: 101] [Article Influence: 22.6] [Reference Citation Analysis]
126 Wang J, Yang L, Diao Y, Liu J, Li J, Li R, Zheng L, Zhang K, Ma Y, Hao X. Circulating tumour DNA methylation in hepatocellular carcinoma diagnosis using digital droplet PCR. J Int Med Res 2021;49:300060521992962. [PMID: 33750234 DOI: 10.1177/0300060521992962] [Reference Citation Analysis]
127 Li Z, Heng J, Yan J, Guo X, Tang L, Chen M, Peng L, Wu Y, Wang S, Xiao Z, Deng Z, Dai L, Wang J. Integrated analysis of gene expression and methylation profiles of 48 candidate genes in breast cancer patients. Breast Cancer Res Treat 2016;160:371-83. [DOI: 10.1007/s10549-016-4004-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
128 Feng N, Wang Y, Zheng M, Yu X, Lin H, Ma R, Shi O, Zheng X, Gao M, Yu H, Garmire L, Qian B. Genome-wide analysis of DNA methylation and their associations with long noncoding RNA/mRNA expression in non-small-cell lung cancer. Epigenomics 2017;9:137-53. [DOI: 10.2217/epi-2016-0120] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
129 Wang J, Zhao YY, Li JF, Guo CC, Chen FR, Su HK, Zhao HF, Long YK, Shao JY, To Ss, Chen ZP. IDH1 mutation detection by droplet digital PCR in glioma. Oncotarget 2015;6:39651-60. [PMID: 26485760 DOI: 10.18632/oncotarget.5630] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
130 Li M, Xie S, Lu C, Zhu L, Zhu L. Application of Data Science in Circulating Tumor DNA Detection: A Promising Avenue Towards Liquid Biopsy. Front Oncol 2021;11:692322. [PMID: 34367974 DOI: 10.3389/fonc.2021.692322] [Reference Citation Analysis]
131 Cohen JD, Diergaarde B, Papadopoulos N, Kinzler KW, Schoen RE. Tumor DNA as a Cancer Biomarker through the Lens of Colorectal Neoplasia. Cancer Epidemiol Biomarkers Prev 2020;29:2441-53. [PMID: 33033144 DOI: 10.1158/1055-9965.EPI-20-0549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Cheng F, Su L, Qian C. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer. Oncotarget. 2016;7:48832-48841. [PMID: 27223063 DOI: 10.18632/oncotarget.9453] [Cited by in Crossref: 107] [Cited by in F6Publishing: 110] [Article Influence: 26.8] [Reference Citation Analysis]
133 Jiang P, Sun K, Tong YK, Cheng SH, Cheng THT, Heung MMS, Wong J, Wong VWS, Chan HLY, Chan KCA, Lo YMD, Chiu RWK. Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma. Proc Natl Acad Sci U S A 2018;115:E10925-33. [PMID: 30373822 DOI: 10.1073/pnas.1814616115] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 15.0] [Reference Citation Analysis]
134 Stewart CM, Kothari PD, Mouliere F, Mair R, Somnay S, Benayed R, Zehir A, Weigelt B, Dawson SJ, Arcila ME, Berger MF, Tsui DW. The value of cell-free DNA for molecular pathology. J Pathol 2018;244:616-27. [PMID: 29380875 DOI: 10.1002/path.5048] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 13.3] [Reference Citation Analysis]
135 Sun K, Li L, Ma L, Zhao Y, Deng L, Wang H, Sun H. Msuite: A High-Performance and Versatile DNA Methylation Data-Analysis Toolkit. Patterns (N Y) 2020;1:100127. [PMID: 33294868 DOI: 10.1016/j.patter.2020.100127] [Reference Citation Analysis]
136 Mathai RA, Vidya RVS, Reddy BS, Thomas L, Udupa K, Kolesar J, Rao M. Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology. J Clin Med 2019;8:E373. [PMID: 30889786 DOI: 10.3390/jcm8030373] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 15.0] [Reference Citation Analysis]
137 Vong JSL, Ji L, Heung MMS, Cheng SH, Wong J, Lai PBS, Wong VWS, Chan SL, Chan HLY, Jiang P, Chan KCA, Chiu RWK, Lo YMD. Single Cell and Plasma RNA Sequencing for RNA Liquid Biopsy for Hepatocellular Carcinoma. Clin Chem 2021;67:1492-502. [PMID: 34463757 DOI: 10.1093/clinchem/hvab116] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Bryzgunova O, Bondar A, Ruzankin P, Laktionov P, Tarasenko A, Kurilshikov A, Epifanov R, Zaripov M, Kabilov M, Laktionov P. Locus-Specific Methylation of GSTP1, RNF219, and KIAA1539 Genes with Single Molecule Resolution in Cell-Free DNA from Healthy Donors and Prostate Tumor Patients: Application in Diagnostics. Cancers (Basel) 2021;13:6234. [PMID: 34944854 DOI: 10.3390/cancers13246234] [Reference Citation Analysis]
139 Chan SL, Wong AM, Lee K, Wong N, Chan AK. Personalized therapy for hepatocellular carcinoma: Where are we now? Cancer Treatment Reviews 2016;45:77-86. [DOI: 10.1016/j.ctrv.2016.02.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
140 Ignatiadis M, Dawson SJ. Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality? Ann Oncol 2014;25:2304-13. [PMID: 25336116 DOI: 10.1093/annonc/mdu480] [Cited by in Crossref: 103] [Cited by in F6Publishing: 93] [Article Influence: 12.9] [Reference Citation Analysis]
141 Wang D, O'Rourke D, Sanchez-Garcia JF, Cai T, Scheuenpflug J, Feng Z. Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients. BMC Cancer 2021;21:797. [PMID: 34243735 DOI: 10.1186/s12885-021-08497-x] [Reference Citation Analysis]
142 Li F, Qiao CY, Gao S, Fan YC, Chen LY, Wang K. Circulating cell-free DNA of methylated insulin-like growth factor-binding protein 7 predicts a poor prognosis in hepatitis B virus-associated hepatocellular carcinoma after hepatectomy. Free Radic Res 2018;52:455-64. [PMID: 29463155 DOI: 10.1080/10715762.2018.1443448] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
143 Liu Y, Siejka-zielińska P, Velikova G, Bi Y, Yuan F, Tomkova M, Bai C, Chen L, Schuster-böckler B, Song C. Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution. Nat Biotechnol 2019;37:424-9. [DOI: 10.1038/s41587-019-0041-2] [Cited by in Crossref: 113] [Cited by in F6Publishing: 88] [Article Influence: 37.7] [Reference Citation Analysis]
144 Shi J, Zhang R, Li J, Zhang R. Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing. Theranostics 2020;10:4737-48. [PMID: 32308746 DOI: 10.7150/thno.42565] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
145 Bonner ER, Bornhorst M, Packer RJ, Nazarian J. Liquid biopsy for pediatric central nervous system tumors. NPJ Precis Oncol 2018;2:29. [PMID: 30588509 DOI: 10.1038/s41698-018-0072-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
146 Ulz P, Auer M, Heitzer E. Detection of Circulating Tumor DNA in the Blood of Cancer Patients: An Important Tool in Cancer Chemoprevention. Methods Mol Biol 2016;1379:45-68. [PMID: 26608289 DOI: 10.1007/978-1-4939-3191-0_5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
147 Grabuschnig S, Soh J, Heidinger P, Bachler T, Hirschböck E, Rosales Rodriguez I, Schwendenwein D, Sensen CW. Circulating cell-free DNA is predominantly composed of retrotransposable elements and non-telomeric satellite DNA. Journal of Biotechnology 2020;313:48-56. [DOI: 10.1016/j.jbiotec.2020.03.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
148 Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV; CCGA Consortium. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol 2020;31:745-59. [PMID: 33506766 DOI: 10.1016/j.annonc.2020.02.011] [Cited by in Crossref: 181] [Cited by in F6Publishing: 134] [Article Influence: 90.5] [Reference Citation Analysis]
149 Heitzer E, Ulz P, Geigl JB, Speicher MR. Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies. Mol Oncol 2016;10:494-502. [PMID: 26778171 DOI: 10.1016/j.molonc.2015.12.004] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.9] [Reference Citation Analysis]
150 Jiang P, Lo YD. The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics. Trends in Genetics 2016;32:360-71. [DOI: 10.1016/j.tig.2016.03.009] [Cited by in Crossref: 162] [Cited by in F6Publishing: 142] [Article Influence: 27.0] [Reference Citation Analysis]
151 Strand SH, Orntoft TF, Sorensen KD. Prognostic DNA methylation markers for prostate cancer. Int J Mol Sci. 2014;15:16544-16576. [PMID: 25238417 DOI: 10.3390/ijms150916544] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 8.3] [Reference Citation Analysis]
152 Xie H, Kim RD. The Application of Circulating Tumor DNA in the Screening, Surveillance, and Treatment Monitoring of Colorectal Cancer. Ann Surg Oncol 2021;28:1845-58. [PMID: 32776184 DOI: 10.1245/s10434-020-09002-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
153 Legendre C, Gooden GC, Johnson K, Martinez RA, Liang WS, Salhia B. Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer. Clin Epigenetics 2015;7:100. [PMID: 26380585 DOI: 10.1186/s13148-015-0135-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
154 Bliskunova T, Genis-Mendoza AD, Martínez-Magaña JJ, Vega-Sevey JG, Jiménez-Genchi J, Roche A, Guzmán R, Zapata L, Castro-Chavira S, Fernández T, Villatoro-Velázquez JA, Camarena B, Fleiz-Bautista C, Bustos-Gamiño M, Medina-Mora ME, Nicolini H. Association of MGAT4C with major neurocognitive disorder in the Mexican population. Gene 2021;778:145484. [PMID: 33581268 DOI: 10.1016/j.gene.2021.145484] [Reference Citation Analysis]
155 Bronkhorst AJ, Ungerer V, Holdenrieder S. Early detection of cancer using circulating tumor DNA: biological, physiological and analytical considerations. Crit Rev Clin Lab Sci 2019;:1-17. [PMID: 31865831 DOI: 10.1080/10408363.2019.1700902] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
156 Yang Z, Jin M, Zhang Z, Lu J, Hao K. Classification Based on Feature Extraction For Hepatocellular Carcinoma Diagnosis Using High-throughput Dna Methylation Sequencing Data. Procedia Computer Science 2017;107:412-7. [DOI: 10.1016/j.procs.2017.03.130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
157 Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20:71-88. [PMID: 30410101 DOI: 10.1038/s41576-018-0071-5] [Cited by in Crossref: 363] [Cited by in F6Publishing: 344] [Article Influence: 121.0] [Reference Citation Analysis]
158 Huang J, Soupir AC, Wang L. Cell-free DNA methylome profiling by MBD-seq with ultra-low input. Epigenetics 2021;:1-14. [PMID: 33724157 DOI: 10.1080/15592294.2021.1896984] [Reference Citation Analysis]
159 Papadopoulos N. Pathophysiology of ctDNA Release into the Circulation and Its Characteristics: What Is Important for Clinical Applications. Recent Results Cancer Res 2020;215:163-80. [PMID: 31605229 DOI: 10.1007/978-3-030-26439-0_9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
160 Perakis S, Auer M, Belic J, Heitzer E. Advances in Circulating Tumor DNA Analysis. Adv Clin Chem 2017;80:73-153. [PMID: 28431643 DOI: 10.1016/bs.acc.2016.11.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
161 Zhang P, Wu X, Tang M, Nie X, Li L. Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma. Thorac Cancer 2019;10:2218-24. [PMID: 31602787 DOI: 10.1111/1759-7714.13201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
162 Lo YMD, Han DSC, Jiang P, Chiu RWK. Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science 2021;372:eaaw3616. [PMID: 33833097 DOI: 10.1126/science.aaw3616] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
163 Gao J, Wang H, Zang W, Li B, Rao G, Li L, Yu Y, Li Z, Dong B, Lu Z, Jiang Z, Shen L. Circulating tumor DNA functions as an alternative for tissue to overcome tumor heterogeneity in advanced gastric cancer. Cancer Sci. 2017;108:1881-1887. [PMID: 28677165 DOI: 10.1111/cas.13314] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
164 Gai W, Sun K. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy. Genes (Basel) 2019;10:E32. [PMID: 30634483 DOI: 10.3390/genes10010032] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 17.7] [Reference Citation Analysis]
165 Tse OYO, Jiang P, Cheng SH, Peng W, Shang H, Wong J, Chan SL, Poon LCY, Leung TY, Chan KCA, Chiu RWK, Lo YMD. Genome-wide detection of cytosine methylation by single molecule real-time sequencing. Proc Natl Acad Sci U S A 2021;118:e2019768118. [PMID: 33495335 DOI: 10.1073/pnas.2019768118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
166 Lapin M, Oltedal S, Tjensvoll K, Buhl T, Smaaland R, Garresori H, Javle M, Glenjen NI, Abelseth BK, Gilje B, Nordgård O. Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. J Transl Med 2018;16:300. [PMID: 30400802 DOI: 10.1186/s12967-018-1677-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
167 Kumar P, Dillon LW, Shibata Y, Jazaeri AA, Jones DR, Dutta A. Normal and Cancerous Tissues Release Extrachromosomal Circular DNA (eccDNA) into the Circulation. Mol Cancer Res 2017;15:1197-205. [PMID: 28550083 DOI: 10.1158/1541-7786.MCR-17-0095] [Cited by in Crossref: 66] [Cited by in F6Publishing: 40] [Article Influence: 13.2] [Reference Citation Analysis]
168 Liu Z, Wang Z, Jia E, Ouyang T, Pan M, Lu J, Ge Q, Bai Y. Analysis of genome-wide in cell free DNA methylation: progress and prospect. Analyst 2019;144:5912-22. [DOI: 10.1039/c9an00935c] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
169 Lin E, Chien J, Ong FS, Fan J. Challenges and opportunities for next-generation sequencing in companion diagnostics. Expert Review of Molecular Diagnostics 2015;15:193-209. [DOI: 10.1586/14737159.2015.961916] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
170 Wielscher M, Vierlinger K, Kegler U, Ziesche R, Gsur A, Weinhäusel A. Diagnostic Performance of Plasma DNA Methylation Profiles in Lung Cancer, Pulmonary Fibrosis and COPD. EBioMedicine. 2015;2:927-934. [PMID: 26425700 DOI: 10.1016/j.ebiom.2015.06.025] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 7.4] [Reference Citation Analysis]
171 Ma M, Zhang S, Lu C, Wang S, Yao Y, Peng H. Chromosome constitution of equal-sized three-cell embryos using next-generation sequencing technology. J Assist Reprod Genet 2019;36:307-14. [PMID: 30443691 DOI: 10.1007/s10815-018-1362-7] [Reference Citation Analysis]
172 Sun K, Jiang P, Cheng SH, Cheng THT, Wong J, Wong VWS, Ng SSM, Ma BBY, Leung TY, Chan SL, Mok TSK, Lai PBS, Chan HLY, Sun H, Chan KCA, Chiu RWK, Lo YMD. Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin. Genome Res 2019;29:418-27. [PMID: 30808726 DOI: 10.1101/gr.242719.118] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 21.3] [Reference Citation Analysis]
173 Vendrell JA, Mau-Them FT, Béganton B, Godreuil S, Coopman P, Solassol J. Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management. Int J Mol Sci 2017;18:E264. [PMID: 28146051 DOI: 10.3390/ijms18020264] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 10.4] [Reference Citation Analysis]
174 Chen F, Huang X, Lv J, Wen D, Zhou G, Lin L, Kou J, Wu C, Chen Y, Zheng Z, Li Z, He X, Sun Y. Prognostic potential of liquid biopsy tracking in the posttreatment surveillance of patients with nonmetastatic nasopharyngeal carcinoma. Cancer 2020;126:2163-73. [DOI: 10.1002/cncr.32770] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
175 Barrow TM, Michels KB. Epigenetic epidemiology of cancer. Biochem Biophys Res Commun. 2014;455:70-83. [PMID: 25124661 DOI: 10.1016/j.bbrc.2014.08.002] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
176 Wong FC, Sun K, Jiang P, Cheng YK, Chan KA, Leung TY, Chiu RW, Lo YMD. Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approaches. Clinical Biochemistry 2016;49:1379-86. [DOI: 10.1016/j.clinbiochem.2016.09.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
177 Ye Q, Ling S, Zheng S, Xu X. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Mol Cancer. 2019;18:114. [PMID: 31269959 DOI: 10.1186/s12943-019-1043-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 22.0] [Reference Citation Analysis]
178 Gao F, Xia Y, Wang J, Lin Z, Ou Y, Liu X, Liu W, Zhou B, Luo H, Zhou B, Wen B, Zhang X, Huang J. Integrated analyses of DNA methylation and hydroxymethylation reveal tumor suppressive roles of ECM1, ATF5, and EOMES in human hepatocellular carcinoma. Genome Biol 2014;15:533. [PMID: 25517360 DOI: 10.1186/s13059-014-0533-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
179 Cutts A, Venn O, Dilthey A, Gupta A, Vavoulis D, Dreau H, Middleton M, McVean G, Taylor JC, Schuh A. Characterisation of the changing genomic landscape of metastatic melanoma using cell free DNA. NPJ Genom Med 2017;2:25. [PMID: 29075515 DOI: 10.1038/s41525-017-0030-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
180 Cruz A, Peng WK. Perspective: Cellular and Molecular Profiling Technologies in Personalized Oncology. J Pers Med 2019;9:E44. [PMID: 31547284 DOI: 10.3390/jpm9030044] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
181 Xu W, Yu J, Wong VW. Mechanism and prediction of HCC development in HBV infection. Best Practice & Research Clinical Gastroenterology 2017;31:291-8. [DOI: 10.1016/j.bpg.2017.04.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
182 Panagopoulou M, Esteller M, Chatzaki E. Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine. Cancers (Basel) 2021;13:728. [PMID: 33578793 DOI: 10.3390/cancers13040728] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
183 Lo YMD. Noninvasive prenatal testing complicated by maternal malignancy: new tools for a complex problem. NPJ Genom Med 2016;1:15002. [PMID: 29263801 DOI: 10.1038/npjgenmed.2015.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
184 Chan KC. Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma. Chin J Cancer 2014;33:598-603. [PMID: 25418194 DOI: 10.5732/cjc.014.10192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 34] [Article Influence: 0.8] [Reference Citation Analysis]
185 Campos-Carrillo A, Weitzel JN, Sahoo P, Rockne R, Mokhnatkin JV, Murtaza M, Gray SW, Goetz L, Goel A, Schork N, Slavin TP. Circulating tumor DNA as an early cancer detection tool. Pharmacol Ther 2020;207:107458. [PMID: 31863816 DOI: 10.1016/j.pharmthera.2019.107458] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
186 Liu HH, Fang Y, Wang JW, Yuan XD, Fan YC, Gao S, Han LY, Wang K. Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma. Medicine (Baltimore) 2020;99:e20326. [PMID: 32443384 DOI: 10.1097/MD.0000000000020326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Chan LL, Jiang P. Bioinformatics analysis of circulating cell-free DNA sequencing data. Clin Biochem 2015;48:962-75. [PMID: 25966961 DOI: 10.1016/j.clinbiochem.2015.04.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
188 Wu L, Qu X. Cancer biomarker detection: recent achievements and challenges. Chem Soc Rev 2015;44:2963-97. [DOI: 10.1039/c4cs00370e] [Cited by in Crossref: 535] [Cited by in F6Publishing: 110] [Article Influence: 76.4] [Reference Citation Analysis]
189 Li Z, Guo X, Wu Y, Li S, Yan J, Peng L, Xiao Z, Wang S, Deng Z, Dai L, Yi W, Xia K, Tang L, Wang J. Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients. Breast Cancer Res Treat 2015;149:767-79. [DOI: 10.1007/s10549-015-3276-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
190 Chiu RWK. Fastidious Detection of Circulating Tumor DNA Mutations in Residual Breast Cancer Disease for Ultimate Analytical Sensitivity and Specificity. Clin Chem 2020;66:866-7. [PMID: 32215639 DOI: 10.1093/clinchem/hvaa068] [Reference Citation Analysis]
191 Galardi F, Luca F, Romagnoli D, Biagioni C, Moretti E, Biganzoli L, Leo AD, Migliaccio I, Malorni L, Benelli M. Cell-Free DNA-Methylation-Based Methods and Applications in Oncology. Biomolecules 2020;10:E1677. [PMID: 33334040 DOI: 10.3390/biom10121677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
192 Hutson N, Zhan F, Graham J, Murakami M, Zhang H, Ganaparti S, Hu Q, Yan L, Ma C, Liu S, Xie J, Wei L. An adaptive method of defining negative mutation status for multi-sample comparison using next-generation sequencing. BMC Med Genomics 2021;14:32. [PMID: 34856988 DOI: 10.1186/s12920-021-00880-8] [Reference Citation Analysis]
193 Li W, Zhang X, Lu X, You L, Song Y, Luo Z, Zhang J, Nie J, Zheng W, Xu D, Wang Y, Dong Y, Yu S, Hong J, Shi J, Hao H, Luo F, Hua L, Wang P, Qian X, Yuan F, Wei L, Cui M, Zhang T, Liao Q, Dai M, Liu Z, Chen G, Meckel K, Adhikari S, Jia G, Bissonnette MB, Zhao Y, Zhang W, He C, Liu J. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers. Cell Res. 2017;27:1243-1257. [PMID: 28925386 DOI: 10.1038/cr.2017.121] [Cited by in Crossref: 123] [Cited by in F6Publishing: 110] [Article Influence: 24.6] [Reference Citation Analysis]
194 Daniūnaitė K, Jarmalaitė S, Kriukienė E. Epigenomic technologies for deciphering circulating tumor DNA. Current Opinion in Biotechnology 2019;55:23-9. [DOI: 10.1016/j.copbio.2018.07.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
195 Leal A, Sidransky D, Brait M. Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer Detection. Clin Chem 2020;66:105-16. [PMID: 31843869 DOI: 10.1373/clinchem.2019.303594] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
196 Yang M, Forbes ME, Bitting RL, O'Neill SS, Chou PC, Topaloglu U, Miller LD, Hawkins GA, Grant SC, DeYoung BR, Petty WJ, Chen K, Pasche BC, Zhang W. Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system? Ann Oncol 2018;29:311-23. [PMID: 29216340 DOI: 10.1093/annonc/mdx766] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 12.7] [Reference Citation Analysis]
197 Singh RR, Reindl KM, Jansen RJ. Epigenomics of Pancreatic Cancer: A Critical Role for Epigenome-Wide Studies. Epigenomes 2019;3:5. [PMID: 31772762 DOI: 10.3390/epigenomes3010005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
198 Jiang P, Chan KCA, Lo YMD. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies. J Hepatol 2019;71:409-21. [PMID: 31004682 DOI: 10.1016/j.jhep.2019.04.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
199 Shen SY, Singhania R, Fehringer G, Chakravarthy A, Roehrl MHA, Chadwick D, Zuzarte PC, Borgida A, Wang TT, Li T, Kis O, Zhao Z, Spreafico A, Medina TDS, Wang Y, Roulois D, Ettayebi I, Chen Z, Chow S, Murphy T, Arruda A, O'Kane GM, Liu J, Mansour M, McPherson JD, O'Brien C, Leighl N, Bedard PL, Fleshner N, Liu G, Minden MD, Gallinger S, Goldenberg A, Pugh TJ, Hoffman MM, Bratman SV, Hung RJ, De Carvalho DD. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature. 2018;563:579-583. [PMID: 30429608 DOI: 10.1038/s41586-018-0703-0] [Cited by in Crossref: 264] [Cited by in F6Publishing: 229] [Article Influence: 66.0] [Reference Citation Analysis]
200 Li LS, Guo XY, Sun K. Recent advances in blood-based and artificial intelligence-enhanced approaches for gastrointestinal cancer diagnosis. World J Gastroenterol 2021; 27(34): 5666-5681 [PMID: 34629793 DOI: 10.3748/wjg.v27.i34.5666] [Reference Citation Analysis]
201 Grabuschnig S, Bronkhorst AJ, Holdenrieder S, Rosales Rodriguez I, Schliep KP, Schwendenwein D, Ungerer V, Sensen CW. Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms. Int J Mol Sci 2020;21:E8062. [PMID: 33137955 DOI: 10.3390/ijms21218062] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
202 [DOI: 10.1101/478065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
203 Maravelia P, Silva DN, Rovesti G, Chrobok M, Stål P, Lu YC, Pasetto A. Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy. Cancers (Basel) 2021;13:4334. [PMID: 34503144 DOI: 10.3390/cancers13174334] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
204 Gai W, Zhou Z, Agbor-Enoh S, Fan X, Lian S, Jiang P, Cheng SH, Wong J, Chan SL, Jang MK, Yang Y, Liang RH, Chan WK, Ma ES, Leung TY, Chiu RW, Valantine H, Chan KA, Lo YD. Applications of genetic-epigenetic tissue mapping for plasma DNA in prenatal testing, transplantation and oncology. Elife 2021;10:e64356. [PMID: 33752803 DOI: 10.7554/eLife.64356] [Reference Citation Analysis]
205 Tabata M, Miyahara Y. Liquid biopsy in combination with solid-state electrochemical sensors and nucleic acid amplification. J Mater Chem B 2019;7:6655-69. [DOI: 10.1039/c9tb00718k] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
206 Tran NH, Kisiel J, Roberts LR. Using cell-free DNA for HCC surveillance and prognosis. JHEP Rep 2021;3:100304. [PMID: 34136776 DOI: 10.1016/j.jhepr.2021.100304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Chen S, Liu T, Bu D, Zhu J, Wang X, Pan Y, Liu Y, Lu ZJ, Wang P. Methylome profiling identifies TCHH methylation in CfDNA as a noninvasive marker of liver metastasis in colorectal cancer. FASEB J 2021;35:e21720. [PMID: 34110642 DOI: 10.1096/fj.202100266R] [Reference Citation Analysis]
208 Qi Q, Lu S, Zhou X, Yao F, Hao N, Yin G, Li W, Bai J, Li N, Cram DS. Copy number variation sequencing-based prenatal diagnosis using cell-free fetal DNA in amniotic fluid: CNV sequencing analysis of cffDNA in AF. Prenat Diagn 2016;36:576-83. [DOI: 10.1002/pd.4830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
209 Jaworski JJ, Morgan RD, Sivakumar S. Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer. Cancers (Basel) 2020;12:E3704. [PMID: 33317202 DOI: 10.3390/cancers12123704] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
210 Cirillo M, Craig AFM, Borchmann S, Kurtz DM. Liquid biopsy in lymphoma: Molecular methods and clinical applications. Cancer Treat Rev 2020;91:102106. [PMID: 33049623 DOI: 10.1016/j.ctrv.2020.102106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
211 Rice A, Del Rio Hernandez A. The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA. Front Oncol 2019;9:952. [PMID: 31608239 DOI: 10.3389/fonc.2019.00952] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
212 Cullinane C, Fleming C, O'Leary DP, Hassan F, Kelly L, O'Sullivan MJ, Corrigan MA, Redmond HP. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open 2020;3:e2026921. [PMID: 33211112 DOI: 10.1001/jamanetworkopen.2020.26921] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]